Efficacy of 14-d vs 7-d moxifloxacin-based triple regimens for second-line Helicobacter pylori eradication

doi:10.3748/wjg.v21.i18.5568

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 21, Issue 18

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (5801)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-3) series.

Item

Count

PDF

315

WORD

159

HTML

2692

Figures (1-1)

145

Tables (1-3)

144

Sum=3455

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

952

Download

1394

Sum=2346

May 14, 2015 (publication date) through Apr 28, 2024

Times Cited of This Article

Times Cited (9)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. May 14, 2015; 21(18): 5568-5574
Published online May 14, 2015. doi: 10.3748/wjg.v21.i18.5568

Table 3 Adverse events n (%)

Adverse events	RAM-7 (n = 72)	RAM-14 (n = 73)	P value
Epigastric discomfort	3 (4.1)	5 (6.8)	0.874
Constipation	0 (0.0)	1 (1.4)	0.411
Diarrhea	4 (5.5)	6 (8.2)	0.991
Dizziness	1 (1.4)	1 (1.4)	0.667
Headache	0 (0.0)	1 (1.4)	0.667
Nausea or vomiting	6 (8.3)	1 (1.4)	0.415
Skin rash	0 (0.0)	0 (0.0)	-
Total	14 (19.4)	15 (20.5)	0.441

RAM-7: Rabeprazole/amoxicillin/moxifloxacin triple therapy x 7 d; RAM-14: Rabeprazole/amoxicillin/moxifloxacin triple therapy x 14 d; ITT: Intention-to-treat; PP: Per-protocol.

Citation: Hwang JJ, Lee DH, Lee AR, Yoon H, Shin CM, Park YS, Kim N. Efficacy of 14-d vs 7-d moxifloxacin-based triple regimens for second-line Helicobacter pylori eradication. World J Gastroenterol 2015; 21(18): 5568-5574
URL: https://www.wjgnet.com/1007-9327/full/v21/i18/5568.htm
DOI: https://dx.doi.org/10.3748/wjg.v21.i18.5568